Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would hope that CDMO is picking up the difference since their large expansion. Still don't know why they don't buy CDMO and have everything in house.
I don't understand why HALO hasn't bought already. Seems to me like a perfect fit.
Memory isn't what it used to be
How many of us were here when this was HTIC on OTC? Just curious
Is HALO also using Catalent? Or some other supplier as well?
Win-win for all.
Btw, I didn't say it wasn't going well. I said it takes time for any new drug given the logistics. I think they're doing a great job or i wouldn't have invested in them.
Checked out the drug with CVS and was told about specialty pharmas. I'm a COPD patient and respiratory therapist and have followed trials for quite a while and am delighted to try this drug. Was told the same thing by Verona when I signed up for the drug through the patient portal. I used to teach the mechanism of action of bronchodilators. Specifically C3-5AMP . Taught therapists, nurses, and many of the older physicians sat in for refresher.
Check with your pharmacist and see if it's available. I'd be interested in your findings.
I think it will be January b4 the roll out is complete. Specialty pharmas until then. Have patience, this drug will be a blockbuster with its double mechanism of action.
Thank you for this. Perhaps Dupixent should be looking at us for their AI. That should be an easy sell for HALO.
Wonder where Sanofi got the molecule for subq Dupixent used in copd trials. Any thoughts?
Are we supplying Hylenex for Dupixent? Memory slipping...
I think it is subdermal shot given once to a total of 32 patients. I could very well be wrong.
Is HALO supplying Apogee for their P1 Apg808 copd/anti inflammatory trial?
Thank you both.
Will someone differentiate this tech from HALO's for me. This sounds like direct competition...
Are they not stepping all over HALO's patents?
Thanks for the update--comforting.
I guess the bar Helen referenced isn't as high as we were lead to believe. I agree, very disturbing
I've owned this since 2002.
Will the fireside chat be webcast?
Don't we remember him well...
Been in since Oncolym. Should have sold at 16 but didn't. Finally in the black.
This is a big deal. Can't believe it took 10 months to get through FDA.
Can anyone explain this selloff?
Can anyone explain why HALO continues to drop? Are inst. bailing out?
Got it. Thanks
All I see are Form 4's
I bought in because of Oncolym and Legere
I remember the crows
Maybe LeGere
Maybe she's looking at Avid. Good match in long run.
I'm in for 2
Amen.
I think I remember you from the Avastin and our VTA days with Oxigene. It's been a long ride since Oncolym and Stone days.
Thanks so much for the link.
Very impressive presentation.
The ultrasonic nebulizer would be the aerosol of choice for deepest penetration. I was surprised halo didn't try this when they did the pancreatic trial.
Amen.
Thought we only needed 15 mil. Why so much more?
Profit this quarter?
You were right about fill & finish. Not flush. Senior moment. Thanks
I believe that meeting was cancelled.
Avid has talked in the past for the need for flush and fill. This may turn out to be a better option. No cash mentioned.